Welcome to the Science of Nuclear Receptor Targeting
and Retinoid & Rexinoid Therapeutics

Friday, November 21 2008
Our mission is to develop and deliver the next generation of targeted, highly selective retinoid and rexinoid therapeutics

Learn More

News

Feb 28, 2008

IND for NRX5183 Approved Read More.

Feb 01, 2008

IND for NRX5183 Approved Read More.

Feb 01, 2008

Russo Partners retained for Investor Relations services Read More.

 
...
...